Tag phase_i [34 articles] Export Sort

Recent papers classified by the tag phase_i.

Hide details

	Performance-based readability testing of participant materials for a phase I trial: TGN1412 [My Copy] J Med Ethics, Vol. 35, No. 9. (1 September 2009), pp. 573-578. by P. Knapp, D. K. Raynor, J. Silcock, B. Parkinson posted to phase_i consent by ErinC on 2009-09-30 17:41:50 as
	Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2. [My Copy] Biochemical pharmacology, Vol. 73, No. 12. (15 June 2007), pp. 1853-1862. by C. Köhle, K. W. Bock posted to ah_receptor nrf2 phase_i phase_ii xenobiotic_metabolism by HEIRS to the group HEIRS Particulate Matter and Air Pollutants on 2008-11-30 12:28:06 as along with 1 person and 6 groups billxia HEIRS Oxidative Stress HEIRS Immunology and Autoimmune Diseases HEIRS - Environmental Illness Research HEIRS Environmental Health and Hazards HEIRS Environmental Ecology and related health hazards HEIRS Cellular Biology
	An optimization algorithm for designing phase I cancer clinical trials [My Copy] Contemporary Clinical Trials, Vol. 29, No. 2. (March 2008), pp. 102-108. by Hui Jiang, Yifan Liu, Zheng Su posted to algorithm_based_design clinical_trial phase_i by wbrady5 on 2008-03-05 16:30:06 as
	A Bayesian evaluation of enrolling additional patients at the maximum tolerated dose in Phase I trials [My Copy] Contemporary Clinical Trials, Vol. 26, No. 2. (April 2005), pp. 131-140. by Mithat Gonen posted to bayesian phase_i by wbrady5 on 2008-02-26 02:28:35 as
	Clinical Trial Designs for Cytostatic Agents: Are New Approaches Needed? [My Copy] J Clin Oncol, Vol. 19, No. 1. (1 January 2001), pp. 265-272. by Edward L. Korn, Susan G. Arbuck, James M. Pluda, Richard Simon, Richard S. Kaplan, Michaele C. Christian posted to clinical_trial cytostatic phase_i phase_ii phase_iii by wbrady5 on 2008-02-22 15:01:50 as
	Optimal phase I dose-escalation trial designs in oncology - A simulation study [My Copy] Statistics in Medicine, Vol. 9999, No. 9999. (2007), n/a. by Oke Gerke, Harald Siedentop posted to clinical_trial phase_i simulation by wbrady5 on 2008-01-26 00:22:32 as
	Design and Analysis of Phase I Clinical Trials [My Copy] Biometrics, Vol. 45, No. 3. (1989), pp. 925-937. by Barry E. Storer posted to clinical_trial phase_i by wbrady5 on 2008-01-17 22:28:02 as
	3 + 3 != (Rolling) 6 [My Copy] J Clin Oncol, Vol. 26, No. 2. (10 January 2008), pp. 170-171. by Christine Hartford, Samuel L. Volchenboum, Susan L. Cohn posted to clinical_trial editorial pediatric phase_i by wbrady5 on 2008-01-09 22:30:31 as
	Shortening the Timeline of Pediatric Phase I Trials: The Rolling Six Design [My Copy] J Clin Oncol, Vol. 26, No. 2. (10 January 2008), pp. 190-195. by Jeffrey M. Skolnik, Jeffrey S. Barrett, Bhuvana Jayaraman, Dimple Patel, Peter C. Adamson posted to ab_design clinical_trial pediatric phase_i by wbrady5 on 2008-01-09 22:29:45 as
	Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials [My Copy] Biostat, Vol. 2, No. 2. (1 June 2001), pp. 203-215. by Yong Lin, Weichung J. Shih posted to algorithm_based_design clinical_trial phase_i by wbrady5 on 2008-01-09 15:11:16 as
	Accelerated titration designs for phase I clinical trials in oncology [My Copy] J. Natl. Cancer Inst., Vol. 89, No. 15. (6 August 1997), pp. 1138-1147. by R. Simon, B. Freidlin, L. Rubinstein, S. G. Arbuck, J. Collins, M. C. Christian posted to ab_design clinical_trial phase_i by wbrady5 on 2008-01-07 19:46:36 as
	Simulation as a design tool for phase I/II clinical trials: An example from bone marrow transplantation [My Copy] Controlled Clinical Trials, Vol. 15, No. 6. (December 1994), pp. 450-462. by Ted A. Gooley, Paul J. Martin, Lloyd D. Fisher, Mary Pettinger posted to clinical_trial phase_i phase_ii simulation by wbrady5 on 2008-01-07 13:58:52 as
	A New Dose-Finding Design for Bivariate Outcomes [My Copy] Biometrics, Vol. 59, No. 4. (2003), pp. 1001-1007. by Anastasia Ivanova posted to bivariate clinical_trial phase_i by wbrady5 on 2008-01-04 22:08:03 as
	Two-Dimensional Dose Finding in Discrete Dose Space [My Copy] Biometrics, Vol. 61, No. 1. (March 2005), pp. 217-222. by Kai Wang, Anastasia Ivanova posted to bayesian combination_therapy continual_reassessment_method phase_i by wbrady5 on 2008-01-04 22:05:21 as
	Retrospective Analysis of Sequential Dose-Finding Designs [My Copy] Biometrics, Vol. 61, No. 3. (2005), pp. 749-756. by John O'Quigley posted to ab_design clinical_trial continual_reassessment_method phase_i by wbrady5 on 2008-01-04 22:01:02 as
	A Parallel Phase III Clinical Trial Design for Combination Therapies [My Copy] Biometrics, Vol. 63, No. 2. (June 2007), pp. 429-436. by Huang, Xuelin, Biswas, et al. Swati, Oki, Yasuhiro, Issa, Jean-Pierre, Berry, A. Donald posted to bayesian bivariate clinical_trial combination_therapy phase_i phase_ii toxicity by wbrady5 on 2008-01-04 21:59:15 as
	Bayesian Dose-Finding in Phase III Clinical Trials Using Toxicity and Efficacy Odds Ratios [My Copy] Biometrics, Vol. 62, No. 3. (September 2006), pp. 777-787. by Yin, Guosheng, Li, Yisheng, Ji, Yuan posted to adaptive bayesian bivariate clinical_trial phase_i by wbrady5 on 2008-01-04 21:51:07 as
	A Bayesian Approach to Jointly Modeling Toxicity and Biomarker Expression in a Phase I/II Dose-Finding Trial [My Copy] Biometrics, Vol. 61, No. 2. (June 2005), pp. 343-354. by B. Nebiyou, Yu Shen posted to bayesian biomarker clinical_trial phase_i phase_ii toxicity by wbrady5 on 2008-01-04 21:46:56 as
	Sequential Designs for Phase I Clinical Trials with Late-Onset Toxicities [My Copy] Biometrics, Vol. 56, No. 4. (2000), pp. 1177-1182. by Ying K. Cheung, Rick Chappell posted to clinical_trial continual_reassessment_method phase_i by wbrady5 on 2008-01-04 21:45:12 as
	Designs for Single- or Multiple-Agent Phase I Trials [My Copy] Biometrics, Vol. 60, No. 3. (2004), pp. 661-669. by Mark R. Conaway, Stephanie Dunbar, Shyamal D. Peddada posted to clinical_trial combination_therapy phase_i toxicity by wbrady5 on 2008-01-04 21:35:23 as
	Bayesian Optimal Designs for Phase I Clinical Trials [My Copy] Biometrics, Vol. 59, No. 3. (2003), pp. 591-600. by Linda M. Haines, Inna Perevozskaya, William F. Rosenberger posted to bayesian clinical_trial optimal_design phase_i by wbrady5 on 2008-01-04 21:33:54 as
	Dose-Finding with Two Agents in Phase I Oncology Trials [My Copy] Biometrics, Vol. 59, No. 3. (2003), pp. 487-496. by Peter F. Thall, Randall E. Millikan, Peter Mueller, Sang J. Lee posted to bayesian clinical_trial combination_therapy phase_i toxicity by wbrady5 on 2008-01-04 21:31:11 as
	Adaptive Dose Selection Using Efficacy-Toxicity Trade-Offs: Illustrations and Practical Considerations [My Copy] Journal of Biopharmaceutical Statistics, Vol. 16, No. 5. (2006), pp. 623-638. by Peter F. Thall, John D. Cook, Elihu H. Estey posted to bayesian bivariate clinical_trial continual_reassessment_method phase_i by wbrady5 on 2008-01-02 22:12:27 as along with 1 person austin987
	An Evaluation of a Bayesian Method of Dose Escalation Based on Bivariate Binary Responses [My Copy] Journal of Biopharmaceutical Statistics, Vol. 14, No. 4. (2004), pp. 969-983. by John Whitehead, Yinghui Zhou, John Stevens, Graham Blakey posted to bayesian bivariate continual_reassessment_method phase_i by wbrady5 on 2008-01-02 22:09:55 as
	Three-dose-cohort designs in cancer phase I trials [My Copy] Statistics in Medicine, Vol. 9999, No. 9999. (2007), n/a. by Bo Huang, Rick Chappell posted to continual_reassessment_method multiple_dosing phase_i by wbrady5 on 2007-12-21 21:50:21 as
	Phase I Studies of Chemotherapeutic Agents in Cancer Patients: A Review of the Designs [My Copy] Journal of Biopharmaceutical Statistics, Vol. 16, No. 5. (2006), pp. 579-604. by Douglas M. Potter posted to clinical_trial phase_i review by wbrady5 on 2007-12-21 19:46:24 as along with 1 person austin987
	Another look at two phase I clinical trial designs [My Copy] Statistics in Medicine, Vol. 18, No. 20. (1999), pp. 2683-2690. by John O'Quigley posted to continual_reassessment_method phase_i up_and_down_design by wbrady5 on 2007-12-11 19:57:08 as
	Methods for dose finding studies in cancer clinical trials: A review and results of a monte carlo study [My Copy] Statistics in Medicine, Vol. 10, No. 11. (1991), pp. 1647-1664. by John O'Quigley, Sylvie Chevret posted to phase_i by wbrady5 on 2007-12-11 19:56:25 as
	AN EXTENSION OF THE CONTINUAL REASSESSMENT METHODS USING A PRELIMINARY UP-AND-DOWN DESIGN IN A DOSE FINDING STUDY IN CANCER PATIENTS, IN ORDER TO INVESTIGATE A GREATER RANGE OF DOSES [My Copy] Statistics in Medicine, Vol. 14, No. 9. (1995), pp. 911-922. by Susanne Møller posted to continual_reassessment_method phase_i up_and_down_design by wbrady5 on 2007-12-11 19:53:56 as
	Some practical improvements in the continual reassessment method for phase I studies [My Copy] Statistics in Medicine, Vol. 14, No. 11. (1995), pp. 1149-1161. by Steven N. Goodman, Marianna L. Zahurak, Steven Piantadosi posted to continual_reassessment_method phase_i by wbrady5 on 2007-12-11 19:46:53 as
	Escalation, group and <I>A</I> + <I>B</I> designs for dose-finding trials [My Copy] Statistics in Medicine, Vol. 25, No. 21. (2006), pp. 3668-3678. by Anastasia Ivanova posted to ab_design phase_i by wbrady5 on 2007-12-11 19:31:52 as
	A non-parametric approach to the design and analysis of two-dimensional dose-finding trials [My Copy] Statistics in Medicine, Vol. 23, No. 12. (2004), pp. 1861-1870. by Anastasia Ivanova, Kai Wang posted to bivariate combination_therapy nonparametric phase_i toxicity by wbrady5 on 2007-12-11 18:50:11 as
	An adaptive phase I design for identifying a biologically optimal dose for dual agent drug combinations [My Copy] Statistics in Medicine, Vol. 26, No. 11. (2007), pp. 2317-2330. by Sumithra J. Mandrekar, Yue Cui, Daniel J. Sargent posted to bivariate combination_therapy continuation-ratio_model efficacy phase_i toxicity by wbrady5 on 2007-12-11 18:48:20 as
	Optimal designs and limiting optimal designs for a trinomial response [My Copy] Journal of Statistical Planning and Inference, Vol. 126, No. 1. (1 November 2004), pp. 347-360. by Kelly, Kathryn Chaloner posted to bivariate continuation-ratio_model optimal_design phase_i phase_ii trinomial_responses by wbrady5 on 2007-10-29 20:25:42 as

Note: You may cite this page as: http://www.citeulike.org/tag/phase_i

Sort by:
Order:	Default Ascending Descending
Empty fields:	Default First Last

clinical_trial	21
phase_ii	13
bayesian	10
continual_reassessment_method	9
ah_receptor	8
bivariate	8
nrf2	8
xenobiotic_metabolism	8
combination_therapy	6
toxicity	6
ab_design	4
algorithm_based_design	3
continuation-ratio_model	2
optimal_design	2
pediatric	2
simulation	2
up_and_down_design	2
adaptive	1
biomarker	1
consent	1
cytostatic	1
editorial	1
efficacy	1
multiple_dosing	1
nonparametric	1
phase_iii	1
review	1
trinomial_responses	1

Tag phase_i [34 articles] Export Sort

Related Tags